The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

November 30, 2010

Conditions
Prostate Cancer
Interventions
DRUG

Silibin-Phytosome

Subjects will take Silibin-Phytosome for 2-10 weeks. The dose of Silibin-Phytosome is 13 grams daily, in three divided doses. Patients will be asked to mix 1 level teaspoon and 1 heaping ¼ teaspoon of Silybin-Phytosome powder into 6 tablespoons of applesauce for each dose.

Trial Locations (1)

80010

University of Colorado Hospital, Aurora

All Listed Sponsors
collaborator

Sir Mortimer B. Davis - Jewish General Hospital

OTHER

lead

University of Colorado, Denver

OTHER

NCT00487721 - The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer | Biotech Hunter | Biotech Hunter